ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 733891 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 733891; 2) Community: the network communities that were significantly associated with the response to NSC 733891; 3) Molecule: the relationships between components within communities and NSC 733891; 4) MDR: the compounds that were significantly associated with the NSC 733891.

NSC Compound Enrichment Correlation
NSC 633498 Null 0.0147237897640499 0.28040676
NSC 671898 Null 0.0147237897640499 -0.055041232
NSC 684836 Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- 0.0147237897640499 0.31491697
NSC 687330 Adenosine, 2'-amino-2'-deoxy-3',5'- O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]- (9CI) 0.0147237897640499 0.19032971
NSC 736164 pyrazoline derivative 0.0147237897640499 0.49396072
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0147237897640499 0.14311213
NSC 735037 Camptothecin Derivative 0.0164116791870034 0.16004017
NSC 736609 Null 0.0164116791870034 0.38191002
NSC 751500 Null 0.0164116791870034 -0.12140196
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0164116791870034 0.1904758
Total:63  Current:22    [First] [Prev] [Next] [Last]